Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension.
Phase of Trial: Phase III
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Moxonidine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 20 Apr 2010 Planned patient number (100) added as reported by ClinicalTrials.gov.
- 07 Sep 2007 Status changed from in progress to completed.
- 29 Oct 2005 New trial record.